Effect of Repetative Transcranial Magnetic Stimulation Therapy on Neuropathic Pain in Patients With Spinal Cord Injury

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The aim of our study is to investigate the effect of high-frequency Repetitive Transcranial Magnetic Stimulation(rTMS) therapy applied to the dorsolateral PFC (DLPFC) area on neuropathic pain in patients with spinal cord injury. In this area, there are very few studies on the effectiveness of rTMS treatment added to medical treatment in neuropathic pain. In addition, the number of studies comparing the effect of rTMS therapy applied to the DLFPC area is very few.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Maximum Age: 70
Healthy Volunteers: f
View:

⁃ Between the ages of 20-70, who applied to the AFSU Physical Medicine and Rehabilitation inpatient service with the diagnosis of spinal cord injury and

• Having spinal cord injury with neurophatic pain at least six months ago,

• Able to follow two-stage verbal commands,

• Agreeing to participate in the study voluntarily and regularly,

• Patients who are medically stable (no previous myocardial infarction, no musculoskeletal problems) will be included in our study.

Locations
Other Locations
Turkey
Afyonkarahisar
RECRUITING
Afyonkarahisar
Contact Information
Primary
Nuran EYVAZ, MD
n_eyvaz@hotmail.com
+905334262442
Time Frame
Start Date: 2022-11-15
Estimated Completion Date: 2025-07-31
Participants
Target number of participants: 60
Treatments
Experimental: High-frequency real-time rTMS protocol
It was planned to apply a total of 1200 beats to the dorsolateral prefrontal cortex daily at a frequency of 10 HZ at 110% intensity of the motor threshold for 15 sessions.
Sham_comparator: Sham rTMS Protocol
It was planned to apply daily sham rTMS to the dorsolateral prefrontal cortex for 15 sessions.
Related Therapeutic Areas
Sponsors
Leads: Afyonkarahisar Health Sciences University

This content was sourced from clinicaltrials.gov